Tumor cells undergoing TF brachyury-mediated EMT to overexpress transmembrane glycoprotein mucin-1 (MUC-1) will exhibit reduced susceptibility to CTL killing even with normal levels of HLA class I, antigenic peptides, and components of the antigen presentation [81]. The gene discussed is TF; the disease is neoplasm.